|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 51, 49815-49819, December 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Division of Research Technologies, Lilly Research
Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285
Protein C is a plasma protease that in its active
form plays a central role in the regulation of vascular function by
modulating thrombosis, inflammation, and apoptosis. A central
player in this pathway is the cytokine-regulated receptor
thrombomodulin (TM), which functions as a co-factor for the
thrombin-dependent generation of activated protein C. We
have found that tumor necrosis factor-
Modulation of Thrombomodulin-dependent
Activation of Human Protein C through Differential Expression of
Endothelial Smads*
(TGF-
)-dependent suppression of TM on endothelial cells
is differentially regulated by endothelial Smad6s and Smad7.
Overexpression of Smad6s resulted in activation of a TGF-
reporter
alone and enhanced TGF-
response. Moreover, Smad6s overexpression
suppressed TM and subsequently reduced activated protein C
generation. Antisense inhibition of Smad6s expression enhanced the
TM-dependent activation of protein C, whereas blocking the
inhibitory Smad7 by antisense resulted in reduced
TM-dependent activation of protein C. The effect of Smad6s
appeared to be due, at least in part, to up-regulation of TGF-
itself. Immunohistochemisty studies in normal versus atherosclerotic vessels showed that TM levels were suppressed in the
endothelium over plaque. Consistent with the in vitro data, we found differential expression of Smad6s and Smad7 in normal versus atherosclerotic vessels, with Smad6s expression low
in normal vessels but elevated in atherosclerotic vessels. In contrast, the opposite expression pattern was observed for Smad7. Overall, our
results suggest that the relative balance of these intracellular Smads
modulate the balance of endothelial function with regard to protein C activation.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Division of Research
Technologies, Lilly Research Laboratories, Lilly Corp. Center, Indianapolis, IN 46285-0444. Tel.: 317-276-2293; Fax: 317-277-2934; E-mail: grinnell@lilly.com.
This article has been cited by other articles:
![]() |
S. J. Peterson, D. Husney, A. L. Kruger, R. Olszanecki, F. Ricci, L. F. Rodella, A. Stacchiotti, R. Rezzani, J. A. McClung, W. S. Aronow, et al. Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gupta, D. T. Berg, B. Gerlitz, G. R. Sharma, S. Syed, M. A. Richardson, G. Sandusky, J. G. Heuer, E. J. Galbreath, and B. W. Grinnell Role of Protein C in Renal Dysfunction after Polymicrobial Sepsis J. Am. Soc. Nephrol., March 1, 2007; 18(3): 860 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Kapur, C. B. Deming, S. Kapur, C. Bian, H. C. Champion, J. K. Donahue, D. A. Kass, and J. J. Rade Hemodynamic Modulation of Endocardial Thromboresistance Circulation, January 2, 2007; 115(1): 67 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.M. Yan, Z.P. Fan, J. Du, H. Hua, Y.Y. Xu, and S.L. Wang A Novel Mutation in ALK-1 Causes Hereditary Hemorrhagic Telangiectasia Type 2. J. Dent. Res., August 1, 2006; 85(8): 705 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Berg, L. J. Myers, M. A. Richardson, G. Sandusky, and B. W. Grinnell Smad6s Regulates Plasminogen Activator Inhibitor-1 through a Protein Kinase C-{beta}-dependent Up-regulation of Transforming Growth Factor-{beta} J. Biol. Chem., April 15, 2005; 280(15): 14943 - 14947. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lin, A. Kumar, S. SenBanerjee, K. Staniszewski, K. Parmar, D. E. Vaughan, M. A. Gimbrone Jr, V. Balasubramanian, G. Garcia-Cardena, and M. K. Jain Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function Circ. Res., March 18, 2005; 96(5): e48 - e57. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. de Wouwer, D. Collen, and E. M. Conway Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1374 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kim, H. S. Lee, H.-J. Lee, K. Hur, W. H. Kim, Y.-J. Bang, S.-J. Kim, K. U. Lee, K. J. Choe, and H.-K. Yang Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas Ann. Onc., April 1, 2004; 15(4): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |